INTRODUCTION: Nanoparticles are used worldwide because of their unique properties, with large-scale application in various fields, such as medicine, cosmetics and industries. In view of their widespread use, the potential adverse effects of nanoparticles have become a significant cause for concern, in terms of not only human health and safety but also the environment. The present investigation focused on establishing the bioaccumulation patterns and ultrastructural changes induced by retained iron oxide nanoparticles (IONPs) in various target organs of rats. METHODS: Twenty-four male Wistar rats were randomly divided into four groups. Experimental animals were intravenously administered different doses of IONPs (7.5 mg/kg, 15 mg/kg and 30 mg/kg) once in a week for 4 weeks. Urine and feces samples were collected on a daily basis to assess nanoparticle clearance and analyzed via atomic absorption spectroscopy (AAS). At the end of the experiment, rats were euthanized and different organs, including spleen, liver, kidney, lung, heart, testis and brain, were dissected. Bioaccumulation of iron in organs and ultrastructural changes induced by IONPs were determined. RESULTS: The maximal concentration of iron was detected in spleen and minimal concentration in the brain. The level of iron accumulation in organs was as follows: spleen>blood>liver>kidney>lung>heart>testis>brain. The excretion profile in urine revealed maximum excretion on the day following administration that was maintained until day 28, whereas the iron content in feces remained high during the first three days after injection. A similar pattern was observed throughout the duration of the experiment. Ultrastructural alterations were detected in spleen, kidney, lung, heart, testis, brain and liver, indicative of cellular damage induced by accumulating nanoparticles in these organs. CONCLUSION: Intravenous administration of IONPs results in ultrastructural changes and dose-dependent bioaccumulation in different organs of rats.
INTRODUCTION: Nanoparticles are used worldwide because of their unique properties, with large-scale application in various fields, such as medicine, cosmetics and industries. In view of their widespread use, the potential adverse effects of nanoparticles have become a significant cause for concern, in terms of not only human health and safety but also the environment. The present investigation focused on establishing the bioaccumulation patterns and ultrastructural changes induced by retained iron oxide nanoparticles (IONPs) in various target organs of rats. METHODS: Twenty-four male Wistar rats were randomly divided into four groups. Experimental animals were intravenously administered different doses of IONPs (7.5 mg/kg, 15 mg/kg and 30 mg/kg) once in a week for 4 weeks. Urine and feces samples were collected on a daily basis to assess nanoparticle clearance and analyzed via atomic absorption spectroscopy (AAS). At the end of the experiment, rats were euthanized and different organs, including spleen, liver, kidney, lung, heart, testis and brain, were dissected. Bioaccumulation of iron in organs and ultrastructural changes induced by IONPs were determined. RESULTS: The maximal concentration of iron was detected in spleen and minimal concentration in the brain. The level of iron accumulation in organs was as follows: spleen>blood>liver>kidney>lung>heart>testis>brain. The excretion profile in urine revealed maximum excretion on the day following administration that was maintained until day 28, whereas the iron content in feces remained high during the first three days after injection. A similar pattern was observed throughout the duration of the experiment. Ultrastructural alterations were detected in spleen, kidney, lung, heart, testis, brain and liver, indicative of cellular damage induced by accumulating nanoparticles in these organs. CONCLUSION: Intravenous administration of IONPs results in ultrastructural changes and dose-dependent bioaccumulation in different organs of rats.
Authors: Günter Oberdörster; Andrew Maynard; Ken Donaldson; Vincent Castranova; Julie Fitzpatrick; Kevin Ausman; Janet Carter; Barbara Karn; Wolfgang Kreyling; David Lai; Stephen Olin; Nancy Monteiro-Riviere; David Warheit; Hong Yang Journal: Part Fibre Toxicol Date: 2005-10-06 Impact factor: 9.400
Authors: Anil Patri; Thomas Umbreit; J Zheng; K Nagashima; Peter Goering; Sabine Francke-Carroll; Edward Gordon; James Weaver; Terry Miller; Nakissa Sadrieh; Scott McNeil; Mel Stratmeyer Journal: J Appl Toxicol Date: 2009-11 Impact factor: 3.446
Authors: Andrew A Burns; Jelena Vider; Hooisweng Ow; Erik Herz; Oula Penate-Medina; Martin Baumgart; Steven M Larson; Ulrich Wiesner; Michelle Bradbury Journal: Nano Lett Date: 2009-01 Impact factor: 11.189
Authors: Mohamed F Dora; Nabil M Taha; Mohamed A Lebda; Aml E Hashem; Mohamed S Elfeky; Yasser S El-Sayed; Soad Al Jaouni; Ali H El-Far Journal: Int J Mol Sci Date: 2021-04-07 Impact factor: 5.923
Authors: Katrin Radeloff; Andreas Radeloff; Mario Ramos Tirado; Agmal Scherzad; Rudolf Hagen; Norbert H Kleinsasser; Stephan Hackenberg Journal: Nanomaterials (Basel) Date: 2020-04-13 Impact factor: 5.076
Authors: Guilherme A Soares; João V C Faria; Leonardo A Pinto; Andre G Prospero; Gabriele M Pereira; Erick G Stoppa; Lais P Buranello; Andris F Bakuzis; Oswaldo Baffa; José R A Miranda Journal: Materials (Basel) Date: 2022-03-14 Impact factor: 3.623